203 related articles for article (PubMed ID: 34855554)
41. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.
Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K
Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982
[TBL] [Abstract][Full Text] [Related]
42. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
43. Knockdown of terminal differentiation induced ncRNA (TINCR) suppresses proliferation and invasion in hepatocellular carcinoma by targeting the miR-218-5p/DEAD-box helicase 5 (DDX5) axis.
Zhao H; Xie Z; Tang G; Wei S; Chen G
J Cell Physiol; 2020 Oct; 235(10):6990-7002. PubMed ID: 31994189
[TBL] [Abstract][Full Text] [Related]
44. TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection.
Wang CH; Guo ZY; Chen ZT; Zhi XT; Li DK; Dong ZR; Chen ZQ; Hu SY; Li T
Sci Rep; 2015 Jul; 5():12366. PubMed ID: 26190376
[TBL] [Abstract][Full Text] [Related]
45. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
[TBL] [Abstract][Full Text] [Related]
46. lncRNA DRHC inhibits proliferation and invasion in hepatocellular carcinoma via c-Myb-regulated MEK/ERK signaling.
Zhuang R; Zhang X; Lu D; Wang J; Zhuo J; Wei X; Ling Q; Xie H; Zheng S; Xu X
Mol Carcinog; 2019 Mar; 58(3):366-375. PubMed ID: 30362626
[TBL] [Abstract][Full Text] [Related]
47. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
48. FAM83D associates with high tumor recurrence after liver transplantation involving expansion of CD44+ carcinoma stem cells.
Lin B; Chen T; Zhang Q; Lu X; Zheng Z; Ding J; Liu J; Yang Z; Geng L; Wu L; Zhou L; Zheng S
Oncotarget; 2016 Nov; 7(47):77495-77507. PubMed ID: 27769048
[TBL] [Abstract][Full Text] [Related]
49. Demethylation-Induced Overexpression of Shc3 Drives c-Raf-Independent Activation of MEK/ERK in HCC.
Liu Y; Zhang X; Yang B; Zhuang H; Guo H; Wei W; Li Y; Chen R; Li Y; Zhang N
Cancer Res; 2018 May; 78(9):2219-2232. PubMed ID: 29330146
[TBL] [Abstract][Full Text] [Related]
50. CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis.
Jin AL; Zhang CY; Zheng WJ; Xian JR; Yang WJ; Liu T; Chen W; Li T; Wang BL; Pan BS; Li Q; Cheng JW; Wang PX; Hu B; Zhou J; Fan J; Yang XR; Guo W
Clin Transl Med; 2022 Apr; 12(4):e794. PubMed ID: 35384345
[TBL] [Abstract][Full Text] [Related]
51. FBXO17 promotes malignant progression of hepatocellular carcinoma by activating wnt/β-catenin pathway.
Liu FH; Cui YP; He YK; Shu RH
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8265-8273. PubMed ID: 31646557
[TBL] [Abstract][Full Text] [Related]
52. RNA Helicase DDX24 Stabilizes LAMB1 to Promote Hepatocellular Carcinoma Progression.
Liu T; Gan H; He S; Deng J; Hu X; Li L; Cai L; He J; Long H; Cai J; Li H; Zhang Q; Wang L; Chen F; Chen Y; Zhang H; Li J; Yang L; Liu Y; Yang JH; Kuang DM; Pang P; He H; Shan H
Cancer Res; 2022 Sep; 82(17):3074-3087. PubMed ID: 35763670
[TBL] [Abstract][Full Text] [Related]
53. TRIP6 promotes tumorigenic capability through regulating FOXC1 in hepatocellular carcinoma.
Wang F; Zhang B; Xu X; Zhu L; Zhu X
Pathol Res Pract; 2020 Apr; 216(4):152850. PubMed ID: 32046874
[TBL] [Abstract][Full Text] [Related]
54. GABPA predicts prognosis and inhibits metastasis of hepatocellular carcinoma.
Zhang S; Zhang K; Ji P; Zheng X; Jin J; Feng M; Liu P
BMC Cancer; 2017 May; 17(1):380. PubMed ID: 28549418
[TBL] [Abstract][Full Text] [Related]
55. MicroRNA-294 Promotes Cell Proliferation, Migration and Invasion in SMMC-7721 Hepatoma Carcinoma Cells by Activating the JNK/ERK Signaling Pathway.
Cheng X; Chen M; Liu Z
Am J Med Sci; 2020 Jun; 359(6):365-371. PubMed ID: 32498943
[TBL] [Abstract][Full Text] [Related]
56. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
57. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway.
Dong X; Wang F; Xue Y; Lin Z; Song W; Yang N; Li Q
Int J Mol Med; 2019 Mar; 43(3):1417-1429. PubMed ID: 30664155
[TBL] [Abstract][Full Text] [Related]
59. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target.
Chen DT; Pan JH; Chen YH; Xing W; Yan Y; Yuan YF; Zeng WA
Br J Anaesth; 2019 Jun; 122(6):e157-e167. PubMed ID: 30915986
[TBL] [Abstract][Full Text] [Related]
60. PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients.
Han T; Xiang DM; Sun W; Liu N; Sun HL; Wen W; Shen WF; Wang RY; Chen C; Wang X; Cheng Z; Li HY; Wu MC; Cong WM; Feng GS; Ding J; Wang HY
J Hepatol; 2015 Sep; 63(3):651-60. PubMed ID: 25865556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
